Active
    Mainboard

    Rubicon Research Ltd

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Rubicon Research Ltd IPO opened on 09 Oct 2025 and closed on 13 Oct 2025, with a price band of ₹461–₹485 per share. The IPO had a lot size of 30 shares, requiring a minimum investment of ₹14,550 per lot at the upper price band. The issue size was ₹1377.5 crore, and the shares get listed on 16 Oct 2025.

    Rubicon Research Ltd IPO Details

    Listing Date

    16 Oct 2025

    Bid Price

    ₹461 - ₹485

    Lot Size

    30 Shares

    Minimum Investment

    ₹14,550 / Lot

    Issue Size

    ₹1377.5 Cr

    Employee Discount

    ₹46 per share

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    9th Oct

    tick

    Offer End Date

    13th Oct

    tick

    Allotment Date

    14th Oct

    tick

    Refund Initiation

    15th Oct

    tick

    Demat Transfer

    15th Oct

    tick

    Listing Date

    16th Oct

    About Rubicon Research Ltd IPO

    Incorporated in 1999, Rubicon Research Limited is a pharmaceutical company focused on the development, manufacturing, and commercialisation of differentiated formulations. As of June 30, 2025, the company holds approvals for 72 products under the US FDA’s ANDA and NDA framework, with 66 products currently commercialised. Its presence in the US generic pharmaceutical market, valued at USD 2,455.7 million, generated revenue of USD 195 million for Rubicon in Fiscal 2024. The company has an additional 17 products awaiting US FDA approval and 63 products in various stages of development, reflecting a consistent pipeline for future growth.
     

    Rubicon Research also markets over 350 SKUs to 96 customers, including major wholesalers covering more than 90% of wholesale drug distribution in the US. The company extends its operations internationally with 48 product applications across Australia, the UK, Singapore, Saudi Arabia, and the UAE. Its services include contract manufacturing for select customers in India, Australia, and New Zealand. Rubicon operates three manufacturing facilities in India and maintains two US FDA inspected R&D centres in India and Canada, supporting both domestic and international product development.

    Rubicon Research Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 77.34% 61.79%
    Public Group 22.66% 38.21%

    Rubicon Research Ltd IPO Reservation

    QIB Shares Offered 85,09,788 (29.96%)
    NII (HNI) Shares Offered 42,54,894 (14.98%)
    Retail Shares Offered 28,36,596 (9.99%)
    Anchor Investor Shares Offered 1,27,64,681 (44.94%)
    Total Shares Offered 2,84,02,040
    Total Shares With Anchor Investor 2,84,02,040

    Rubicon Research Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 1 30 ₹14,550
    Retail (Max) 13 390 ₹1,89,150
    S HNI (Min) 14 420 ₹2,03,700
    S HNI (Max) 68 2,040 ₹9,89,400
    B HNI (MIN) 69 2,070 ₹10,03,950

    Rubicon Research Ltd IPO Anchor Portion Size

    Bid Date October 08, 2025

    Rubicon Research Ltd IPO registrar

    MUFG Intime India Pvt Ltd
    Phone Number +91 81081 14949
    Email Id rubicon.ipo @linkintime.co.in
    Website https://in.mpms.mufg.com

    Rubicon Research Ltd IPO Lead Manager

    1. Axis Capital Ltd

    2. IIFL Securities Ltd

    3. JM Financial Ltd

    4. SBI Capital Markets Ltd

    Rubicon Research Ltd Financial Information

    March 31, 2025 March 31, 2024 March 31, 2023
    Net Worth ₹540.98 Cr ₹385 Cr ₹286.38 Cr
    Reserves and Surplus ₹525.57 Cr ₹369.79 Cr ₹281.3 Cr
    Total Borrowing ₹393.17 Cr ₹396.41 Cr ₹317.91 Cr

    Strength of Rubicon Research Ltd

    • We are the fastest growing Indian pharmaceutical company amongst our peers and the only Indian company focused completely on the US market.
    • Our data-driven product selection framework has allowed us to build a product portfolio with a combination of new and specialty products allowing us to withstand pricing pressures.
    • Our R&D capabilities and continuing investment allow us to pursue complex products that offer strong revenue opportunities.
    • Robust sales and distribution capabilities in the US.
    • Strong track record of compliance combined with expertise in cost effective manufacturing
    • Experienced and entrepreneurial management team with a proven track record and marquee private equity investor.

    Risks Involved

    • We derive Rs.3,507.36 million and 99.50%, and Rs.12,649.23 million and 98.49%, respectively, of our revenue from operations from the United States for the three month period ended June 30, 2025 and Fiscal 2025, respectively, and any adverse developments in the United States such as imposition of tariffs could have an adverse effect on our business and results of operations.
    • As the manufacture of our products is technically complex and highly regulated, product recalls, regulatory inspection failures or shortcomings at our manufacturing facilities or other problems may reduce sales, adversely affect our business, financial condition and results of operations and delay the launch of new products, and in some cases may lead to closures of our facilities.
    • We have a history of net losses, negative earnings per share ("EPS") and return on capital employed. We need to generate and sustain increased revenues while managing our expenses to achieve profitability, and our inability to achieve these goals may have an adverse effect on our business, results of operations, cash flows and financial condition.
    • In Fiscals 2025, 2024 and 2023, and the three month period ended June 30, 2025 and 2024 we derived 71.22%, 65.14% and 62.99%, and 77.04% and 70.46%, respectively, of our revenue from sale of goods from our top five customers and the loss of one or more such customers could adversely affect our business and prospects.
    • Our operations are subject to high working capital and capital expenditure requirements, and our inability to maintain an optimal level of working capital or financing required may impact our operations adversely.
    • Any disruption, breakdown or shutdown of our research and development and manufacturing facilities may have a material adverse effect on our business, financial condition, results of operations and cash flows.
    • Our Company is involved in certain legal proceedings. Any adverse decision in such proceedings may render us/them liable to liabilities/penalties and may adversely affect our business, financial condition, results of operations and cash flows.
    • Our success depends on our ability to execute our growth strategies. If we are unable to sustain or manage our growth, our business, results of operations, cash flows and financial condition may be adversely affected.
    • We face significant competitive pressures in our business from other pharmaceutical manufacturers. Our inability to compete effectively would be detrimental to our business and prospects for future growth.
    • The market in which we operate is subject to consolidation and disruption, and our inability to navigate such changes could adversely affect our business, financial condition and results of operation.
    stock
    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Industry Outlook of Rubicon Research IPO

    • Indian pharmaceutical formulations sector appears to be growing steadily, especially in regulated markets such as the United States and Europe.

    • Demand in the US generics and specialty products market is under pressure from regulatory complexity, cost of raw materials, and competition from other Asian players.

    • R&D investment is increasing among pharma firms, with more companies seeking ANDA and NDA approvals, drug-device combinations and complex dosage forms.

    • Regulatory requirements (US FDA, WHO-GMP, Health Canada etc.) are shaping manufacturing and compliance costs. Firms with accredited facilities may have smoother paths to market.

    • Global health-crises, supply chain disruptions, and raw material sourcing from China are creating both risks and opportunities for Indian exporters.

    • Domestic growth (India) and demand from Europe may help offset slowing growth in the US market.

    • Firms that maintain a deep product pipeline, ensure high commercialization rates of approved products, and expand manufacturing capacity may have more consistent revenue upside.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Rubicon Research IPO.  

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    SOTEFIN BHARAT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    16th Jul 2026 - 7th Jul 2026
    Price Range
    ₹178.0 - 187.0
    IPO Size
    ₹89,76,00,000
    Bidding Period
    17th Jul 2026 - 7th Jul 2026
    Price Range
    ₹402.0 - 424.0
    IPO Size
    ₹4,49,99,99,744
    GULF LLOYDS INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    20th Jul 2026 - 7th Jul 2026
    Price Range
    ₹100.0 - 100.0
    IPO Size
    ₹18,19,00,000
    • All
    • MainBoard
    • SME
    Metalic Technoforge Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Jul 2026 - 7th Jul 2026
    Price Range
    ₹72.0 - 77.0
    IPO Size
    ₹49,96,00,000
    Cube Highways Trust IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹151.0 - 152.0
    IPO Size
    ₹49,99,99,98,976
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹18,90,00,000
    Xtranet Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹120.0 - 127.0
    IPO Size
    ₹1,70,00,00,000
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AceVector Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Annu Projects Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AOne Steels India Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    APPL Containers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    ALPINE TEXWORLD LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹100.0 - 105.0
    IPO Size
    ₹1,26,24,99,968
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹315.0 - 331.0
    IPO Size
    ₹1,60,33,99,936
    SBI FUNDS MANAGEMENT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹545.0 - 574.0
    IPO Size
    ₹98,12,91,00,800
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹203.0 - 214.0
    IPO Size
    ₹7,42,00,00,256
    DEVSON CATALYST LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹42,34,00,000
    HAPPY STEELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹62.0 - 66.0
    IPO Size
    ₹25,08,00,000
    KUSUMGAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    8th Jul 2026 - 7th Jul 2026
    Price Range
    ₹398.0 - 419.0
    IPO Size
    ₹6,49,99,99,744
    Bidding Period
    3rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹94.0 - 99.0
    IPO Size
    ₹47,91,00,000
    KNACK PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    1st Jul 2026 - 7th Jul 2026
    Price Range
    ₹161.0 - 170.0
    IPO Size
    ₹4,39,49,99,808
    KRATIKAL TECH LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹128.0 - 135.0
    IPO Size
    ₹39,69,00,000
    SEEMAX RESOURCES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹134.0 - 141.0
    IPO Size
    ₹19,74,00,000
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹80.0 - 84.0
    IPO Size
    ₹27,22,00,000
    ATHARVA POLYPLAST LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹55.0 - 60.0
    IPO Size
    ₹27,00,00,000
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹220.0 - 220.0
    IPO Size
    ₹37,36,00,000
    VINIT MOBILE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹150.0 - 158.0
    IPO Size
    ₹34,13,00,000
    TWINKLE PAPERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    29th Jun 2026 - 7th Jul 2026
    Price Range
    ₹64.0 - 69.0
    IPO Size
    ₹28,00,00,000
    Bidding Period
    29th Jun 2026 - 7th Jul 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹44,03,00,000
    AASTHA SPINTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    29th Jun 2026 - 7th Jul 2026
    Price Range
    ₹125.0 - 136.0
    IPO Size
    ₹1,70,00,00,000
    Bidding Period
    25th Jun 2026 - 6th Jun 2026
    Price Range
    ₹94.0 - 99.0
    IPO Size
    ₹47,91,00,000
    CRAZY SNACKS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    25th Jun 2026 - 6th Jun 2026
    Price Range
    ₹39.0 - 42.0
    IPO Size
    ₹31,47,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    214.00
    Listing Day Close
    262.85(22.90%)
    DEVSON CATALYST LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    205.95(74.58%)
    HAPPY STEELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    66.00
    Listing Day Close
    68.50(4.55%)
    KUSUMGAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    419.00
    Listing Day Close
    604.45(44.15%)
    Issue Prize
    99.00
    Listing Day Close
    174.30(75.76%)
    KNACK PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    170.00
    Listing Day Close
    182.70(7.65%)
    KRATIKAL TECH LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    135.00
    Listing Day Close
    182.40(34.81%)
    SEEMAX RESOURCES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    141.00
    Listing Day Close
    107.20(-24.11%)
    Issue Prize
    84.00
    Listing Day Close
    93.45(10.71%)
    ATHARVA POLYPLAST LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    60.00
    Listing Day Close
    72.45(20.00%)
    Issue Prize
    220.00
    Listing Day Close
    438.90(99.55%)
    VINIT MOBILE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    158.00
    Listing Day Close
    147.25(-6.96%)
    Issue Prize
    70.00
    Listing Day Close
    82.16(17.14%)
    AASTHA SPINTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    136.00
    Listing Day Close
    136.45(0.00%)
    Issue Prize
    99.00
    Listing Day Close
    174.30(75.76%)
    CRAZY SNACKS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    42.00
    Listing Day Close
    45.67(9.52%)
    CSM TECHNOLOGIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    113.00
    Listing Day Close
    107.35(-5.31%)
    Issue Prize
    808.00
    Listing Day Close
    667.35(-17.45%)
    ADVIT JEWELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    138.00
    Listing Day Close
    178.15(28.99%)
    RIYAASAT LIFESTYLE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    106.00
    Listing Day Close
    80.60(-23.58%)

    Frequently Asked Questions

    What is Rubicon Research Ltd IPO?

    Answer Field

    Rubicon Research Ltd IPO is a Mainboard IPO of 2,84,02,040 equity shares of a face value of ₹1 aggregating up to ₹1377.5 Crores. The issue is priced at ₹461 to ₹485 per share. The minimum order quantity is 30 Shares. The IPO opens on October 09, 2025, and closes on October 13, 2025. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

    When Rubicon Research Ltd IPO will open?

    Answer Field

    The Rubicon Research Ltd IPO opens on October 09, 2025 and closes on October 13, 2025.

    What is the lot size of Rubicon Research Ltd?

    Answer Field

    Rubicon Research Ltd lot size is 30 shares, and the minimum amount required is ₹14,550.

    How to apply for Rubicon Research Ltd IPO?

    Answer Field

    You can apply in Rubicon Research Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Rubicon Research Ltd IPO allotment?

    Answer Field

    The finalization of Basis of Allotment for Rubicon Research Ltd IPO will be done on October 14, 2025, and the allotted shares will be credited to your demat account by October 15, 2025.

    When is Rubicon Research Ltd IPO listing date?

    Answer Field

    The Rubicon Research Ltd listing date is October 16, 2025.

    Who is the registrar of Rubicon Research Ltd IPO?

    Answer Field

    The registrar of Rubicon Research Ltd IPO is MUFG Intime India Pvt Ltd

    Which company is the book-running lead manager of the IPO?

    Answer Field

    Axis Capital Ltd,IIFL Securities Ltd,JM Financial Ltd,SBI Capital Markets Ltd will be the book-running lead manager of this IPO.

    What is the fresh issue of Rubicon Research Ltd IPO?

    Answer Field

    The fresh issue size is ₹500 Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Rubicon Research Ltd?

    Answer Field

    Retail investors can subscribe to a minimum of one lot, 30 shares and ₹14,550 amount.

    How can I approve the UPI mandate request for Rubicon Research Ltd IPO?

    Answer Field

    To apply for Rubicon Research Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Rubicon Research Ltd?

    Answer Field

    The price of each Rubicon Research Ltd share will be ranging in between ₹461 to ₹485 per share.

    What is the cut-off time for the UPI mandate for Rubicon Research Ltd IPO?

    Answer Field

    The cut-off time for the UPI mandate confirmation is 5:00 PM, October 13, 2025.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |